Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anika Therapeutics Inc. - Common Stock (NQ:ANIK)

9.740 -0.010 (-0.10%)
Streaming Delayed Price Updated: 3:18 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Anika Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting
From Anika Therapeutics Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
 
Via Benzinga
Anika Therapeutics Earnings Preview
 
Via Benzinga
Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
From Anika Therapeutics Inc.
Via GlobeNewswire
New FDA 510(k) Clearance Expands Anika's Sports Medicine Soft Tissue Portfolio
 
Via Benzinga
Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Issues Statement
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States
From Anika Therapeutics Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... 
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
7 Stocks to Buy Before the Market Starts to Soar in 2023
With the market falling into a bit of disarray, astute investors can leverage this moment to dive into compelling stocks to buy. 
Via InvestorPlace
Anika Therapeutics Cingal Tops Steroid For Osteoarthritis Pain Relief
 
Via Benzinga
Anika’s Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Therapeutics: Q2 Earnings Insights
Anika Therapeutics (NASDAQ:ANIK) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Anika Receives the ACE Award for Cutting-Edge Innovation for Tactoset® Injectable Bone Substitute from the American Orthopedic Society for Sports Medicine
From Anika Therapeutics Inc.
Via GlobeNewswire
Sidoti's Summer Small Cap Virtual Conference
NEW YORK, NY / ACCESSWIRE / June 14, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day Summer Small Cap Virtual Conference taking place Wednesday and... 
From Sidoti & Company, LLC
Via AccessWire
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 35 companies made new 52-week lows. 52-Week High And Low Highlights: The company with the largest market cap to set a new 52-week low was... 
Via Benzinga
Anika Therapeutics: Q4 Earnings Insights
Anika Therapeutics (NASDAQ:ANIK) reported its Q4 earnings results on Tuesday, March 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative... 
Via Benzinga
Earnings Scheduled For March 8, 2022
Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •... 
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... 
Via Benzinga
Anika Therapeutics, inc (ANIK) Q3 2021 Earnings Call Transcript
ANIK earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Return on Capital Employed Insights for Anika Therapeutics
After pulling data from Benzinga Pro it seems like during Q2, Anika Therapeutics (NASDAQ:ANIK) earned $9.18 million, a 629.73% increase from the preceding quarter. Anika... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2021
Upgrades According to Maxim Group, the prior rating for VirTra Inc (NASDAQ: 
Via Benzinga
Anika Therapeutics, inc (ANIK) Q2 2021 Earnings Call Transcript
ANIK earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 16, 2021
Upgrades According to Citigroup, the prior rating for Alcoa Corp (NYSE: 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.